IPO Announced
Hemab Therapeutics Holdings IPO
US$302m raised
Lodged 30 Apr 2026 · NASDAQ: COAG
Advisers
Lead managers
- Lead manager
- Bookrunner
- Legal adviser
- Issuer
- Hemab Therapeutics Holdings
- Issuer based in
- United States
- Sector
- Biotech
- Tags
- Biotech, Pharma
Similar deals
- Avalyn Pharma IPO Apr 2026 · US$300m · Biotech
- Mentari Therapeutics placement May 2026 · US$290m · Biotech
- Veradermics IPO Feb 2026 · US$256m · Dermatology
- Latigo Biotherapeutics IPO Aug 2026 · US$346m · Biotech
- Seaport Therapeutics IPO Apr 2026 · US$255m · Biotech
Sources
- 1 May 2026 Final IPO prospectus (424B4), Hemab Therapeutics Holdings, Inc. sec.gov
- 5 May 2026 Capital Markets Team Guides Underwriting Syndicate on Hemab Therapeutics’ $346.7 Million Upsized Initial Public Offering goodwinlaw.com



